Close

VIVUS to Present at Upcoming Investor Conference Apr 10, 2015 07:00AM
Vivus (VVUS) Q4 Qsymia Sales Meet Expectations, Needham & Company Notes Feb 25, 2015 08:51AM
Notable Analyst Rating Changes 1/23: (LNKD) (LULU) (CHK) Upgraded; (X) (DWA) (XOM) Downgraded Jan 23, 2015 11:18AM
Pre-Open Stock Movers 11/04: (PLNR) (SWIR) (ACAS) (DATA) Higher; (SZYM) (GNW) (QCOM) (Z) Lower (more...) Nov 6, 2014 09:30AM
Unusual 11 Mid-Day Movers 9/18: (EMKR) (VVUS) (XXII) Higher; (MCHX) (VHC) (ECTE) Lower Sep 18, 2014 12:59PM
View Older Stories

May 6, 2014 06:58AM Vivus (VVUS) Revenue/Rx Improving, Needham & Company Notes
Apr 11, 2014 06:30AM Vivus (VVUS) Qsymia Numbers Lowered at Needham & Company
Apr 3, 2014 07:09AM Vivus, Inc. (VVUS) to Present at 13th Annual Needham Healthcare Conference
Feb 25, 2014 08:31AM Vivus (VVUS) Qsymia Sales Lackluster and Partner Continues to be a Challenge: Needham & Company
Jul 19, 2013 10:50AM Needham & Company Downgrades Vivus (VVUS) to Hold; Sees Disruption Following Settlement
May 3, 2013 09:20AM VIVUS (VVUS) to Report Q1 Results May 8th; Focus on Promotions vs. New Rx
Apr 22, 2013 08:32AM VIVUS (VVUS) Plans to Present at Four Conferences Through End of May
Mar 4, 2013 02:18PM Needham Sees Strong Start for Arena's (ARNA) Belviq in U.S.; European Approval Unlikely
Feb 26, 2013 08:21AM Needham & Company Sees 2nd-Half Qsymia Ramp for Vivus (VVUS)
Jan 4, 2013 03:25PM Despite Slow Launch, Vivus's (VVUS) Qsymia Still Has Blockbuster Potential
Nov 6, 2012 03:02PM Needham & Company Cuts Numbers on VIVUS Inc. (VVUS) on Slower Qsymia Launch, Keeps Buy on Blockbuster Potential
Sep 24, 2012 07:31AM Needham & Company Cuts Target on Vivus (VVUS), Adjusts Qsymia Estimates
May 8, 2012 08:23AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Expect Approval of Qnexa by the PDUFA Date
Apr 25, 2012 11:28AM Notable Analyst Rating Changes 04/25: (JCP) (AAPL) (STM) Upgraded; (PGR) (CRDN) (WMT) Downgraded
Apr 10, 2012 07:36AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Qnexa PDUFA Date Extension Doesn't Change Our View
Feb 16, 2012 09:23AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Qnexa FDA Advisory Committee Meeting Preview
Jan 6, 2012 11:04AM Needham & Company reiterates a 'Buy' on Vivus (VVUS); 2012 Preview - Qnexa and Avanafil FDA Decisions in April
Dec 22, 2011 04:10PM Vivus (VVUS) Shares Fall on Data Results, Downgrades, Though One Firm Remains Optimistic
Dec 22, 2011 08:09AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); FORTRESS Results Announced
Nov 8, 2011 09:19AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); 3Q11 Review: Awaiting FORTRESS Results in December
Sep 22, 2011 04:46PM Needham & Company Maintains a 'Buy' on Vivus (VVUS); Risks Around Topiramate/Phentermine are Manageable
May 3, 2011 07:52AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Retrospective Topiramate Study to be Underway Soon, with Results Likely in 4Q11
Apr 4, 2011 10:17AM Morning Movers 04/04: (MSSR) (OREX) (VVUS) Higher; (AMIE) (DGW) Lower
Mar 1, 2011 08:17AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); 4Q10 Review. Management Guiding for Qnexa NDA Resubmission by YE11
Jan 21, 2011 12:29PM Needham Sees QNEXA's FDA Issues Being Resolved with REMS, Post-Approval Studies; VIVUS (VVUS) Shares Down 15% Today
Jan 21, 2011 10:06AM Morning Movers 01/21: ORCC, DNBK, GENE, WMG, PLCM, HUGH, ISRG, GMXR, SMOD Higher; ACOR, IPCI, VVUS, SYNA Lower
Jan 6, 2011 08:43AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); 1Q11 Preview
Dec 8, 2010 07:50AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Contrave FDA Advisory Committee Vote a Positive for Obesity Space, Qnexa, and Vivus
Oct 29, 2010 01:21PM Unusual 11 Mid-Day Movers 10/29: FMR, MWW, EONC, VVUS, TNAV, CSTR Higher; NR, NUVA, SNBC, EXAS, GRRF Lower
Oct 29, 2010 11:11AM Morning Movers 10/29: FMR, VVUS, MWW, CSTR, TNAV, PTEK, AXTI, EL Higher; NUVA, NR, AMAG, VLCM, TNCC, SNBC, EXAS Lower
Oct 29, 2010 10:53AM Notable Analyst Rating Changes 10/29: MWW, VVUS, MS, LVS Upgraded; FSLR, MEOH, NUVA, AVP Downgraded
Jul 16, 2010 01:13PM Unusual 11 Mid-Day Movers 07/16: LSBX, ARNA, AVII, CYPB, SCHW, TSLA Higher; VVUS, JST, ROIAK, OREX, PLCM Lower
Jul 16, 2010 10:46AM Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
Jul 16, 2010 10:14AM Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
Jul 16, 2010 08:22AM Needham & Company Downgrades VIVUS (VVUS) to Hold Based on Negative Qnexa FDA Advisory Committee Vote
Jul 12, 2010 01:19PM Unusual 11 Mid-Day Movers 07/12: YRCW, PLA, HEW, IFLG, ENCO, LF Higher; BSDM, VVUS, CPRX, ONAV, AON Lower
Jun 29, 2010 07:44AM Needham & Company Reiterates a 'Buy' on VIVUS Inc. (VVUS); We Remain Positively Inclined Ahead of FDA Panel
May 7, 2010 10:54AM Morning Movers 5/7: SXE, NCT, NANO, CDII, COGO, WNC Higher; TRMA, INAP, CAMP, GXDX, POWR, HLIT, HANS Lower
May 4, 2010 08:38AM Needham & Company Reiterates a 'Buy' on VIVUS Inc. (VVUS); Qnexa Program Remains on Track
Apr 27, 2010 11:01AM Notable Analyst Rating Changes 04/27: PPDI, MRVL, TASR, CAVM Upgraded; AIG, HBAN, NWSA, ACN Downgraded
Apr 14, 2010 11:03AM Notable Analyst Rating Changes 04/14: AIB, ERIC, MCD, CREE Upgraded; POT/MOS, TWC/DTV, DNDN, NOK Downgraded
Apr 14, 2010 08:44AM Needham & Company Initiates Coverage on VIVUS Inc. (VVUS) with a Buy; Project a Positive Qnexa Advisory Committee Review and FDA Approval
Apr 14, 2010 06:49AM Needham & Company Starts VIVUS (VVUS) at Buy
Dec 17, 2009 10:51AM Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
View Older Stories